Arkolith/Insider Trading/RXRX/Form 4

Khan Najat

CEO and President, DirectorRECURSION PHARMACEUTICALS, INC. (RXRX) · full profile →Form 4 · filed Feb 10, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2026Grant(A)30K—$02.3M
Feb 6, 2026Grant(A)1.7M—$02.3M
Feb 6, 2026Tax withholding(F)10K$3.98$41K2.3M

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001601830-26-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML